Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04735341

Enrollment

Registered

2021-02-03

Start date

2020-12-09

Completion date

2022-06-30

Last updated

2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Pulmonary Nodule, Solitary

Brief summary

The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.

Interventions

DEVICEIon Endoluminal System

Ion Endoluminal Procedure for pulmonary nodule

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Age of 18 years or older * Undergoing a lung biopsy procedure with Ion System * Have peripheral pulmonary lesion (5th bronchial generation or higher) * Willingness to participate as demonstrated by signing the informed consent

Exclusion criteria

* Unable to provide informed consent * Presence of bilateral nodules intended to be biopsied during procedure * The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy * Vulnerable population (e.g., prisoners, mentally disabled)

Design outcomes

Primary

Measure	Time frame	Description
Ion Catheter Shape	Intra-operative	The collection of data relating to the Ion catheter shape

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026